VGLUT3 Antibody, Clone N34/34

Cannot supply to this region.

SKU:: SMC-397
Additional Names:: VGLUT3, VGluT3, VGLU3, SLC17A8, Solute Carrier Family 17 Member 8, Solute Carrier Family 17 (Sodium-Dependent Inorganic Phosphate Cotransporter) Member 8, Solute Carrier Family 17 (Vesicular Glutamate Transporter) Member 8, Vesicular Glutamate Transporter 3, DFNA25, Deafness Autosomal Dominant 25
Application:: IHC, WB, IF, ICC
Concentration:: 1 mg/ml
Species Reactivity:: Rat
Purification:: Protein G Purified
Storage Conditions:: -20[o]C
Supplier:: StressMarq Biosciences
Host:: Mouse
Reactivities:: Human, Mouse, Rat
ABP:: IMP-GEN-2015-06 < 10% Serum <100ml
Buffer:: PBS pH7.4, 50% glycerol, 0.09% sodium azide
Immunogen:: Fusion protein amino acids 546-588 (cytoplasmic C-terminus) of rat VGLUT3
Clone:: N34/34 (Formerly sold as S34-34)
Uniprot:: Q7TSF2
Synonyms:: solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8;solute carrier family 17 (vesicular glutamate transporter), member 8;Solute carrier family 17 member 8;vesicular glutamate transporter 3;Vglut3
Extra Details:: Vesicular Glutamate Transporter 3 (VGLUT3) is a specialized multipass membrane protein localized to synaptic vesicles, where it facilitates the uptake of glutamate-a critical excitatory neurotransmitter-into vesicles for synaptic release. Unlike other VGLUT isoforms, VGLUT3 exhibits a unique and restricted expression pattern, predominantly found in the amygdala, cerebellum, hippocampus, medulla, spinal cord, and thalamus. These brain regions are central to emotion regulation, motor coordination, memory, and sensory processing, all of which are commonly affected in neurodegenerative disorders. VGLUT3 shares approximately 72% sequence homology with VGLUT2 and BNPI, suggesting evolutionary conservation and potential functional overlap, yet it also displays distinct physiological roles. Emerging research implicates VGLUT3 in the pathophysiology of several neurodegenerative diseases, including Parkinson's disease, Alzheimer's disease, and epilepsy, due to its involvement in non-canonical glutamatergic signaling and neuromodulation. Understanding VGLUT3's molecular mechanisms and regional specificity is critical for advancing targeted therapies and biomarker development in neurodegenerative disease research. As a modulator of both excitatory and inhibitory circuits, VGLUT3 represents a promising focal point for neuroscience investigations into synaptic plasticity, neurotransmitter co-release, and circuit dysfunction.

Shipping Conditions:: Blue Ice